Back to Trades
Gibson Christopher
DirectorCIK 0001856369
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 25
- Buy transactions
- 0
- Sell transactions
- 21
- Companies
- 2
- Active
- 2025–2026
Gibson Christopher, Director, has filed 25 reports across 2 companies, totaling $8.8M in disclosed volume. Sales ($7.9M) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
25 loaded
| Jun 5 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $144.8K |
| Jun 4 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Gibson Christopher | Director | Other | $0 |
| May 27 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $123.2K |
| May 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Other | $0 |
| May 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $134.8K |
| Apr 24 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $144.4K |
| Apr 10 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Gibson Christopher | Director | Grant | $0 |
| Apr 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $124.0K |
| Mar 25 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $130.0K |
| Mar 5 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Gibson Christopher | Director | Grant | $0 |
| Mar 5 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Gibson Christopher | Director | Other | $0 |
| Feb 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $138.4K |
| Feb 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $164.8K |
| Jan 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $178.8K |
| Jan 7 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $170.0K |
| Dec 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $180.0K |
| Nov 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $166.4K |
| Nov 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $208.4K |
| Oct 24 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $570.0K |
| Oct 10 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $604.0K |
| Sep 26 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $476.0K |
| Sep 12 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $471.0K |
| Aug 28 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $484.0K |
| Aug 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Other | $0 |
| Aug 13 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $3.3M |
25 filings